367 related articles for article (PubMed ID: 10399778)
1. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains.
Hoshino Y; Yoshikawa K; Inoue Y; Asai S; Nakamura T; Ogino T; Umeda M; Iwamoto A
Radiat Med; 1999; 17(2):115-20. PubMed ID: 10399778
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
3. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
[TBL] [Abstract][Full Text] [Related]
4. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
6. Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy.
Guan JT; Xu XH; Geng YQ; Yu XJ; Wu RH
Brain Res; 2008 Aug; 1227():221-5. PubMed ID: 18602897
[TBL] [Abstract][Full Text] [Related]
7. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
8. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
9. MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.
Blamek S; Larysz D; Ficek K; Sokół M; Miszczyk L; Tarnawski R
Acta Neurochir Suppl; 2010; 106():183-6. PubMed ID: 19812945
[TBL] [Abstract][Full Text] [Related]
10. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
12. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
13. Anterior to posterior hippocampal MRS metabolite difference is mainly a partial volume effect.
Starck G; Vkhoff-Baaz B; Ljungberg M; Malmgren K; Forssell-Aronsson E; Jönsson L; Ekholm S
Acta Radiol; 2010 Apr; 51(3):351-9. PubMed ID: 20201639
[TBL] [Abstract][Full Text] [Related]
14. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.
Lee PL; Yiannoutsos CT; Ernst T; Chang L; Marra CM; Jarvik JG; Richards TL; Kwok EW; Kolson DL; Simpson D; Tang CY; Schifitto G; Ketonen LM; Meyerhoff DJ; Lenkinski RE; Gonzalez RG; Navia BA;
J Magn Reson Imaging; 2003 Jun; 17(6):625-33. PubMed ID: 12766890
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
Kaymak SU; Demir B; Oğuz KK; Sentürk S; Uluğ B
Psychiatry Clin Neurosci; 2009 Jun; 63(3):350-6. PubMed ID: 19566767
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in school-aged autistic children.
Vasconcelos MM; Brito AR; Domingues RC; da Cruz LC; Gasparetto EL; Werner J; Gonçalves JP
J Neuroimaging; 2008 Jul; 18(3):288-95. PubMed ID: 18304036
[TBL] [Abstract][Full Text] [Related]
17. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual variability of striatal (1)H-MRS brain metabolite measurements at 3 T.
Soreni N; Noseworthy MD; Cormier T; Oakden WK; Bells S; Schachar R
Magn Reson Imaging; 2006 Feb; 24(2):187-94. PubMed ID: 16455408
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
20. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
